We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRAP icon
12701
CALL
Wrap Technologies
WRAP
$105M
$18.8K ﹤0.01%
12,900
-7,500
-37% -$9.57K
WSR
12702
DELISTED
Whitestone REIT
WSR
$18.8K ﹤0.01%
1,940
-130,375
-99% -$1.17M
EDZ icon
12703
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.6M
$18.8K ﹤0.01%
+155
New +$19.5K
QCLS
12704
CALL
Q/C Technologies Inc
QCLS
$21.8M
$18.8K ﹤0.01%
4
-21
-84% -$110K
RDI icon
12705
Reading International Class A
RDI
$36.6M
$18.7K ﹤0.01%
7,071
-5,136
-42% -$15.3K
GILT icon
12706
CALL
Gilat Satellite Networks
GILT
$887M
$18.7K ﹤0.01%
3,000
-2,200
-42% -$11.8K
APVO icon
12707
Aptevo Therapeutics
APVO
$4.46M
0
TLIS
12708
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$18.7K ﹤0.01%
+2,592
New +$18.8K
SYM icon
12709
Symbotic
SYM
$5.55B
$18.6K ﹤0.01%
+435
New +$14.3K
PAVM icon
12710
CALL
PAVmed
PAVM
$37.2M
$18.5K ﹤0.01%
101
-32
-24% -$6.4K
VNRX icon
12711
CALL
VolitionRx Ltd
VNRX
$6.89M
$18.5K ﹤0.01%
665
-360
-35% -$11.8K
LYG icon
12712
PUT
Lloyds Banking Group
LYG
$90.1B
$18.5K ﹤0.01%
8,400
+5,300
+171% +$12.2K
VNDA icon
12713
CALL
Vanda Pharmaceuticals
VNDA
$316M
$18.5K ﹤0.01%
2,800
+1,100
+65% +$7.05K
DSP icon
12714
CALL
Viant Technology
DSP
$275M
$18.4K ﹤0.01%
4,000
+300
+8% +$1.33K
CTRM icon
12715
Castor Maritime
CTRM
$22.6M
$18.4K ﹤0.01%
+4,106
New +$24.7K
FFIC
12716
CALL
DELISTED
Flushing Financial
FFIC
$18.4K ﹤0.01%
1,500
-2,800
-65% -$35.2K
PNTG icon
12717
PUT
Pennant Group
PNTG
$1.37B
$18.4K ﹤0.01%
1,500
-1,100
-42% -$14K
TCRT icon
12718
Alaunos Therapeutics
TCRT
$4.71M
$18.4K ﹤0.01%
241
+7
+3% +$566
BANF icon
12719
PUT
BancFirst
BANF
$3.89B
$18.4K ﹤0.01%
200
-1,900
-90% -$160K
SKF icon
12720
PUT
ProShares UltraShort Financials
SKF
$10.4M
$18.4K ﹤0.01%
250
-525
-68% -$41.5K
WTS icon
12721
PUT
Watts Water Technologies
WTS
$12.8B
$18.4K ﹤0.01%
100
MXCT icon
12722
PUT
MaxCyte
MXCT
$136M
$18.4K ﹤0.01%
4,000
+1,400
+54% +$6.43K
RDW icon
12723
PUT
Redwire
RDW
$3.39B
$18.4K ﹤0.01%
7,200
-39,500
-85% -$108K
NAUT icon
12724
Nautilus Biotechnolgy
NAUT
$114M
$18.4K ﹤0.01%
+4,742
New +$13.7K
TBIO
12725
PUT
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$18.3K ﹤0.01%
644
+83
+15% +$3.31K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.